InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-11-18 00:00:00 ET · period of report 2022-09-27 · accession 0001209191-22-057947 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-11-18 2022-09-27+ CPIX Young Caroline Dir P - Purchase $2.49 +500 18.4K +3% +$1,247

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-10-05 P A 20 $2.58 18,428 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2 Common Common Stock 2022-10-06 P A 20 $2.65 18,448 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3 Common Common Stock 2022-10-07 P A 20 $2.66 18,468 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4 Common Common Stock 2022-10-10 P A 20 $2.53 18,488 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5 Common Common Stock 2022-10-11 P A 20 $2.48 18,508 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6 Common Common Stock 2022-10-12 P A 20 $2.49 18,528 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7 Common Common Stock 2022-10-13 P A 20 $2.38 18,548 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8 Common Common Stock 2022-10-14 P A 20 $2.31 18,568 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9 Common Common Stock 2022-10-17 P A 20 $2.33 18,588 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10 Common Common Stock 2022-10-18 P A 20 $2.46 18,608 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11 Common Common Stock 2022-10-19 P A 20 $2.42 18,628 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12 Common Common Stock 2022-10-20 P A 20 $2.44 18,648 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13 Common Common Stock 2022-10-21 P A 20 $2.49 18,668 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14 Common Common Stock 2022-10-24 P A 20 $2.38 18,688 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15 Common Common Stock 2022-10-25 P A 20 $2.44 18,708 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16 Common Common Stock 2022-10-26 P A 20 $2.42 18,728 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17 Common Common Stock 2022-10-27 P A 20 $2.49 18,748 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18 Common Common Stock 2022-10-28 P A 20 $2.52 18,768 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19 Common Common Stock 2022-10-31 P A 20 $2.54 18,788 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20 Common Common Stock 2022-09-29 P A 20 $2.51 18,348 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21 Common Common Stock 2022-09-28 P A 20 $2.52 18,328 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22 Common Common Stock 2022-09-27 P A 20 $2.57 18,308 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23 Common Common Stock 2022-09-30 P A 20 $2.61 18,368 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24 Common Common Stock 2022-10-03 P A 20 $2.54 18,388 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25 Common Common Stock 2022-10-04 P A 20 $2.61 18,408 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.